Abu Dhabi Receives AstraZeneca’s COVID-19 Antibody Drug Evusheld

Abu Dhabi has received the first global shipment of AstraZeneca’s COVID-19 long-acting antibody medication, Evusheld, after gaining emergency use authorisation from the UAE’s Ministry of Health and Prevention.

Evusheld, is designed to prevent severe infection and death amongst immunocompromised patients.

The first doses of Evusheld arrived in Abu Dhabi on Monday following a collaboration of key partners including Rafed, the UAE’s Primary Group Purchasing Organisation, along with Etihad Cargo, AstraZeneca and Abu Dhabi Airports Company.

.@DoHSocial has received the first global shipment of AstraZeneca’s Evusheild (formerly AZD7442), a medication to protect immunocompromised patients against Covid-19. pic.twitter.com/RHf61XcmMU

— مكتب أبوظبي الإعلامي (@admediaoffice) December 20, 2021

The breakthrough medication will be stored at Rafed’s distribution centre to be transported to various destinations.